SCHEMBL4435474

SCHEMBL4435474

CC(C)(C)[Si](C)(C)O[C@@H]1CCNC[C@H]1N(C(=O)O)c1ccncc1NC(=O)c1nc(-c2c(F)cccc2F)ccc1N

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIM2 Q9P1W9 20/20 0.49
PIM1 P11309 19/20 0.49
PIM3 Q86V86 18/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438383 0.87 PIM2 (0.34) PIM2PIM1PIM3
SCHEMBL4437099 0.87 PIM2 (0.34) PIM2PIM1PIM3
SCHEMBL4444690 0.86 PIM3 (0.37) PIM2PIM1PIM3
SCHEMBL4434926 0.81 PIM2 (0.34) PIM2PIM1PIM3
SCHEMBL4437200 0.80 PIM1 (0.38) PIM2PIM1PIM3
SCHEMBL4439852 0.80 PIM3 (0.37) PIM2PIM1PIM3
SCHEMBL1710369 0.79 KDM4E (0.32)
SCHEMBL1710373 0.79 KDM4E (0.32)
SCHEMBL3228821 0.79 KDM4E (0.32)
SCHEMBL3411679 0.77 PIM1 (0.40) PIM2PIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed